Digital The cliff was never the crisis: Pharma’s strategy problem The patent cliff isn't the problem. It's the symptom.
Digital Google AI Overviews: What it means for pharma EVERSANA INTOUCH’s 2026 Pharma AI Overviews Report covers the rapid evolution within the Google AI Overviews landscape.
Digital Trends & Insights: February 2026 – A pharmaphorum industry r... February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.
Sales & Marketing How war in the Middle East is disrupting medical supply chai... The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.
Digital Trends & Insights, January 2026: A pharmaphorum industry rep... Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
